lazertinib - CISMeF

Preferred Label : lazertinib;

MeSH Hyperonym : 2-Propenamide, N-(5-((4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)-2-pyrimidinyl)amino)-4-methoxy-2-(4-morpholinyl)phenyl)-;

UNII : 4A2Y23XK11;

Details

Origin ID

C000707992;

UMLS CUI

C4724849;

ATC code(s)
- lazertinib [ATC Code]
Currated CISMeF NLP mapping
- Lazertinib [NCIt concept]
- Lazertinib [SMS substance]
MeSH term(s) associated for indexing
- morpholines [MeSH Descriptor]
- pyrazoles [MeSH Descriptor]
- pyrimidines [MeSH Descriptor]
Pharmacological action(s)
- protein kinase inhibitors [MeSH Descriptor]
Record concept(s)
- Leclaza [MeSH concept]
- N-(5-((4-(4-((Dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)-2-pyrimidinyl)amino)-4-methoxy-2-(4-morpholinyl)phenyl)acrylamide [MeSH concept]
- lazertinib [MeSH concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Lazertinib [NCIt concept]
- lazertinib [ATC Code]
Validated automatic mappings to BTNT
- lazertinib [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients